CWA Calls for IBM Action in Wake of Cancer Study

A medical study showing higher than normal rates of cancer among employees at IBM is raising alarms among CWA members at the Alliance@IBM/CWA Local 1701.

"This study confirms to those of us working in IBM manufacturing processes that the rumors and talk about high levels of cancers and other health problems from working with toxic substances weren't just idle shop floor talk," Alliance Vice President Earl Mongeon said.

The Alliance is calling on the company as well as local, state and federal officials to make health surveillance of all current and former IBM employees a priority. The company must also increase the use of non-toxic chemicals and reduce employee exposure to harmful substances, leaders say.

Cities and states with computer manufacturing plants are being asked to compile maps of cancer cases near the facilities and in areas where employees live, and make the maps a matter of public record.

The Alliance also wants the company to establish a fund to help defray medical costs for affected IBM workers and their families.

The study, by Dr. Richard Clapp of the Boston University School of Public Health, includes extensive data from IBM's own "Corporate Mortality File," which has records about the deaths of people who worked at IBM's plants for at least five years.

Dr. Clapp's study, a health survey and more information about health issues at IBM are available on the Alliance web site, www.allianceibm.org.